# Olema Pharmaceuticals, Inc.: Form 8-K, filed Jun 13, 2025

- Company: [Olema Pharmaceuticals, Inc.](/companies/olma.md) (CIK 1750284)
- Form: 8-K
- Filed: 2025-06-13
- Accepted by EDGAR: Jun 13, 2025, 20:30 ET
- Period: 2025-06-10
- Accession: 0000950170-25-086256
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1750284/000095017025086256/olma-20250610.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1750284/000095017025086256/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1750284/000095017025086256/olma-20250610.htm

Filed Jun 13, 2025.
Source: SEC EDGAR, the filing index for accession 0000950170-25-086256. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.